Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis.
Shoji KimuraMohammad AbufarajFlorian JanischTakehiro IwataMehdi Kardoust PariziBeat FoersterNicola FossatiAlberto BrigantiShin EgawaMarkus HartenbachShahrokh F ShariatPublished in: Prostate cancer and prostatic diseases (2019)
PSMA-PET before sLND provided highly accurate performance with clinically relevant high positive and negative predictive values for detecting lymph node disease in patients with BCR after local treatment with curative intent for PCa. PSMA-PET can identify the patients who are likely to benefit from sLND and possibly direct to lesion or region-based dissection.
Keyphrases
- pet ct
- lymph node
- prostate cancer
- positron emission tomography
- sentinel lymph node
- end stage renal disease
- neoadjuvant chemotherapy
- radical prostatectomy
- newly diagnosed
- ejection fraction
- rectal cancer
- pet imaging
- chronic kidney disease
- acute lymphoblastic leukemia
- tyrosine kinase
- high resolution
- computed tomography
- early stage
- patient reported
- locally advanced